News | January 24, 2023
Glenmark launches AKYNZEO I.V. in India
It is administered as a single infusion 30 minutes prior to the start of each chemotherapy cycle that helps prevent, both, acute and delayed phases of CINV
It is administered as a single infusion 30 minutes prior to the start of each chemotherapy cycle that helps prevent, both, acute and delayed phases of CINV
Point-of-Care solution to facilitate clinicians in quick and effective decision making
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
The lab is also the first private lab in West India to have built its Mycobacteriology, Mycology, and Molecular Biology departments within a separate Bio Safety Level - 3 (BSL3) bio-containment lab
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalization for heart failure in adults with CKD
Timely screening and accurate detection through precision diagnostics, targeted therapy, risk reducing surgeries, and comprehensive multimodality treatment options have resulted in improving survival rates and quality of life in cancer patients in India
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
The laboratory is equipped to perform high-volume diagnostic testing services
Subscribe To Our Newsletter & Stay Updated
